A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia
NCT00002009 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To determine the maximum tolerated dose (MTD) and toxicity of sargramostim (recombinant granulocyte-macrophage colony-stimulating factor; GM-CSF) given by continuous intravenous infusion (CIV) in patients with leukopenia in association with AIDS virus infection. In addition, single dose and steady state pharmacokinetics will also be determined.
Conditions
- HIV Infections
- Cytopenias
Interventions
- DRUG
-
Sargramostim
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
NCT00000694 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine
NCT00002263 ·Status: COMPLETED ·Phase: NA
-
An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)
NCT00002255 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex
NCT00002281 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex
NCT00002005 ·Status: COMPLETED ·Phase: NA
-
A Study of Stem Cells and Filgrastim
NCT00001071 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex
NCT00002004 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant
NCT00001019 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIV
NCT06557785 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells
NCT03856996 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals
NCT00272493 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
NCT00000976 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
NCT00004579 ·Status: COMPLETED ·Phase: PHASE1
-
Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART
NCT02225665 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years
NCT00006509 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of SAR441236
NCT03705169 ·Status: TERMINATED ·Phase: PHASE1
-
The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine
NCT00001112 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV
NCT00001105 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
NCT00968630 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC
NCT00000680 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV
NCT00021762 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants
NCT05959707 ·Status: SUSPENDED ·Phase: PHASE1
-
Metformin Immunotherapy in HIV Infection
NCT02659306 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients
NCT02500849 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx
NCT00071890 ·Status: COMPLETED ·Phase: PHASE2